Cassava Sciences | PTIE - Trade Creditors


Cassava Sciences reported $46.09M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Biogen USD 432M 18.9M Dec/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Cassava Sciences USD 46.09M 3.27M Sep/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Geron USD 11.11M 2.88M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Novavax USD 15.23M 35.37M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025